Profilo
Martine J.
van Vugt is currently Director at Hollandbio, Non-Executive Director at Merus NV starting in 2025, Chief Strategy Officer & Executive Vice President at Genmab A since 2023, and Member of the Supervisory Board at Flindr Therapeutics BV.
Former positions include Independent Director at Scandion Oncology A from 2022 to 2024 and Independent Member of the Supervisory Board at TME Pharma NV from 2021 to 2023.
Education includes a doctorate from the University of Utrecht and a graduate degree from Wageningen University.
Posizioni attive di Martine van Vugt
| Società | Posizione | Inizio |
|---|---|---|
| GENMAB A/S | Corporate Officer/Principal | 29/03/2023 |
| MERUS N.V. | Direttore/Membro del Consiglio | 12/12/2025 |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer patients | Direttore/Membro del Consiglio | - |
Hollandbio | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Martine van Vugt
| Società | Posizione | Fine |
|---|---|---|
| SCANDION ONCOLOGY A/S | Direttore/Membro del Consiglio | 01/05/2024 |
| TME PHARMA N.V. | Direttore/Membro del Consiglio | 29/06/2023 |
Formazione di Martine van Vugt
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Wageningen University
Wageningen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TME Pharma NV
TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Scandion Oncology A/S
Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
Hollandbio | |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Develops novel therapies for cancer patients | Health Technology |
















